Efficient induction of apoptosis by proteasome inhibitor: bortezomib in the human breast cancer cell line MDA-MB-231

Molecular Chaperone ORP150 in ER Stress–related Diseases

(2013) Magdalena Kusaczuk et al.   CURRENT PHARMACEUTICAL DESIGN

The effect of estrogen on prolidase-dependent regulation of HIF-1α expression in breast cancer cells

(2013) Arkadiusz Surazynski et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8

(2011) M A Laussmann et al.   CELL DEATH AND DIFFERENTIATION

The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death

(2010) Yong Hwan Han et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death

(2010) Yong Hwan Han et al.   DRUG AND CHEMICAL TOXICOLOGY

Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes

(2010) Sven B. Jänen et al.   GLIA

Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors

(2010) Floriana Morgillo et al.   LUNG CANCER

Cyclophosphamide induces premature senescence in normal human fibroblasts by activating MAP kinases

(2009) Arivazhagan Palaniyappan   BIOGERONTOLOGY

The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib

(2009) M. Milani et al.   CANCER RESEARCH

Mitochondrial cell death effectors

(2009) Dirk Brenner et al.   CURRENT OPINION IN CELL BIOLOGY

Cellular Senescence in the Development and Treatment of Cancer

(2009) Gabriele Saretzki   CURRENT PHARMACEUTICAL DESIGN